Opus Genetics, Inc. Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax
Opus Genetics, Inc. (IRD) had Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax of $12.60 thousand as of 2019-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax · last filed 2019-05-10
- 2019-03-31: Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax $12.60K.
- 2018-03-31: Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax $89.38K.
- 2017-12-31: Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax $56.89K.
- 2017-09-30: Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax $14.11K.
| Period end | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax |
|---|---|
| 2019-03-31 | $12.60K 10-Q · filed 2019-05-10 |
| 2018-03-31 | $89.38K 10-Q · filed 2018-05-04 |
| 2017-12-31 | $56.89K 10-K · filed 2019-03-07 |
| 2017-09-30 | $14.11K 10-Q · filed 2017-11-03 |
| 2017-06-30 | $25.70K 10-Q · filed 2017-08-04 |
| 2017-03-31 | $6.33K 10-Q · filed 2017-05-03 |
| 2016-12-31 | $6.32K 10-K · filed 2018-03-09 |
| 2016-09-30 | $6.04K 10-Q · filed 2016-11-04 |
| 2016-06-30 | $1.12K 10-Q · filed 2016-08-05 |
| 2016-03-31 | $3.77K 10-Q · filed 2016-05-06 |
| 2015-12-31 | $18.61K 10-K · filed 2017-02-24 |
| 2015-09-30 | $382.00 10-Q · filed 2015-11-02 |
| 2015-06-30 | $1.63K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $3.08K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $33.77K 10-K · filed 2016-03-14 |
| 2014-09-30 | $43.23K 10-Q · filed 2014-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |